People with cancer now have a multitude of treatment options beyond chemotherapy and radiation. One such advanced approach, called immune checkpoint ...
Roche's acquisition of Poseida Therapeutics (PSTX) for $1.5B joins the growing trend of cell therapies in M&A activities. Check out my review of this deal.